Technology News and Research

RSS

Labcyte awarded 2nd Japanese patent for acoustic-based cell sorting system

Labcyte, the company that developed and commercialized the acoustic transfer of liquids today announced that the Japanese patent office has granted patent 4309131 that covers the design of an acoustic-based system that can sort cells based upon acoustic or other properties and then eject them specifically from a mixed population.

18 Aug 2009

Novel genome-analysis strategy to speed search for gene-disease links

University of Washington (UW) researchers have successfully developed a novel genome-analysis strategy for more rapid, lower cost discovery of possible gene-disease links. By saving time and lowering expenses, the approach makes it feasible for scientists to search for disease-causing genes in people with the same inherited disorder but without any family ties to each other.

18 Aug 2009

Synco Bio to manufacture Versartis type 2 diabetes drug candidate

SynCo Bio Partners, a Netherlands based biopharmaceutical contract manufacturer, and Versartis, Inc. today announced a strategic partnership to produce Versartis' lead drug candidate VRS-859, a novel GLP-1 analog for monthly dosing to treat type 2 diabetes Under the agreement, SynCo will further develop the Versartis existing production process for VRS-859 and optimize the manufacturing process to increase yields for the forthcoming cGMP production.

18 Aug 2009

Ormco Corporation and Align Technology agree to collaborate and settle patent litigation

Ormco Corporation, a subsidiary of Danaher Corporation (NYSE: DHR) today announced that Ormco and Align Technology, Inc. (Nasdaq: ALGN) have agreed to enter into an exclusive collaboration arrangement to jointly develop and market an orthodontic product offering that will provide orthodontic patients a treatment solution that involves a combination of Align's Invisalign(R) system and Ormco's Insignia(R) custom orthodontic bracket and arch wire system.

From Danaher 18 Aug 2009

DNA evidence found at crime scenes can easily be falsified

Nucleix, Ltd., an emerging life science company specializing in forensic DNA analysis, announced that company researchers have proven DNA evidence found at crime scenes can easily be falsified using basic equipment, know-how and access to DNA or a DNA database.

18 Aug 2009

New technology for measuring heart rate via a conventional wrist watch

SPO Medical Inc. (SPOM) announced today that it has successfully demonstrated to several leading sports and fitness watch manufacturers its vital sign technology for measurement of the heart rate via a conventional wrist watch, negating the need of the traditional chest strap currently used by most sports watch manufacturers.

18 Aug 2009

Tiny magnetic particles guide stem cells to damaged tissue

Microscopic magnetic particles have been used to bring stem cells to sites of cardiovascular injury in a new method designed to increase the capacity of cells to repair damaged tissue, UCL scientists announced today.

18 Aug 2009

Human Genome Sciences achieves systemic lupus goals with candidate drug

Human Genome Sciences announced that BENLYSTA™ met the primary endpoint in BLISS-52, the first of two pivotal Phase 3 trials in patients with serologically active systemic lupus erythematosus (SLE). These results show that BENLYSTA™ has the potential to become the first new approved drug in decades giving hope to people living with systemic lupus.

17 Aug 2009

Align Technology settles patent litigation with Ormco

Align Technology, Inc. today announced that it has reached a settlement with Ormco Corporation (Ormco), a subsidiary of Danaher Corporation, to end all pending litigation between the parties and to begin a new strategic collaboration.

From Danaher 17 Aug 2009

Sonosite acquires Cardiodynamics

SonoSite, Inc. (NASDAQ:SONO) today announced that on August 14, 2009, it completed the acquisition of CardioDynamics International Corporation (NASDAQ:CDIC), a leader in impedance cardiography (ICG) for noninvasive hemodynamic assessment.

17 Aug 2009

Astronauts test nutritional supplement formulas in space

After nearly four years of joint research of Houston-based AmeriSciences and NASA / Johnson Space Center (JSC), a senior NASA medical officer has confirmed that two of the resulting nutritional supplement formulas were used and tested in space by the astronauts of mission STS-125 of May 11, 2009 and the mission STS-127 of July 15, 2009 and are now in use and testing aboard the International Space Station.

17 Aug 2009

PEPFAR partners with BD to improve blood collection safety in Africa

PEPFAR and the global medical technology company BD announced an iniative Tuesday that will work to improve blood collection safety in clinics and hospitals in sub-Saharan Africa – an issue that PANA/Afrique en ligne reports has "become more critical than ever in sub-Saharan nations and other developing countries severely impacted by the HIV/AIDS pandemic" (8/12).

16 Aug 2009

Clinton concludes African tour in Cape Verde

"Secretary of State Hillary Clinton arrived in Cape Verde on Friday, the final stop on her seven-nation Africa tour in which she emphasized good governance and urged officials to implement reforms," CNN reports (8/14).

16 Aug 2009

New microneedle-based injection device from Nanopass

Following the World Health Organization (WHO) declaration of a swine flu pandemic, NanoPass Technologies Ltd. (NanoPass) announced today that it has successfully developed a microneedle-based injection device that could dramatically enhance both the effectiveness and supply of pandemic flu vaccines.

14 Aug 2009

Verizon introduces new security capabilities for health care industry

As the health care industry moves from paper-based to electronic record-keeping, protecting confidential patient information becomes vastly more complex. To address this issue, Verizon is unveiling two new capabilities designed to help safeguard the growing exchange of electronic patient data between hospitals, clinics, physicians, insurers and patients.

14 Aug 2009

Human Pheromone Sciences announces Q2 2009 financials

Human Pheromone Sciences, Inc. (OTC Bulletin Board: EROX) today announced results for the three and six months ended June 30, 2009.

13 Aug 2009

Opexa Therapeutics reports Q2 2009 financials

Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company developing a novel T-cell therapy for multiple sclerosis (MS), today reported financial results for the quarter ended June 30, 2009, and provided details on further developments.

13 Aug 2009

Acacia subsidiary acquires rights to biosensor patent

Acacia Research Corporation (Nasdaq:ACTG) announced today that its subsidiary, Acacia Patent Acquisition LLC, has acquired rights to a patent for biosensor technology.

13 Aug 2009

When cell death goes wrong - scientists gain new insights

Medical Research Council (MRC) scientists have made an important advance in understanding the biological processes involved when cells are prompted to die. The work may help scientists to eventually develop new treatments for the many common diseases and conditions which occur when cell death goes wrong.

13 Aug 2009

Wine may offer radioprotective effect for breast cancer patients

Drinking wine while undergoing radiation treatment for breast carcinoma may reduce the incidence of skin toxicity in breast cancer patients, according to a study in the August issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO).

13 Aug 2009